104 related articles for article (PubMed ID: 27177257)
1. Regulation of cytochrome P450 3A4 by small vault RNAb derived from the non-coding vault RNA1 of multidrug resistance-linked vault particle.
Meng C; Wei Z; Zhang Y; Yan L; He H; Zhang L; Xing Q
Mol Med Rep; 2016 Jul; 14(1):387-93. PubMed ID: 27177257
[TBL] [Abstract][Full Text] [Related]
2. The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs.
Persson H; Kvist A; Vallon-Christersson J; Medstrand P; Borg A; Rovira C
Nat Cell Biol; 2009 Oct; 11(10):1268-71. PubMed ID: 19749744
[TBL] [Abstract][Full Text] [Related]
3. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
[TBL] [Abstract][Full Text] [Related]
4. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
[TBL] [Abstract][Full Text] [Related]
5. Ligand-Free Estrogen Receptor
Wang D; Lu R; Rempala G; Sadee W
Mol Pharmacol; 2019 Oct; 96(4):430-440. PubMed ID: 31399483
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
Ghose R; Mallick P; Taneja G; Chu C; Moorthy B
Methods Mol Biol; 2016; 1395():55-68. PubMed ID: 26910068
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens.
von Richter O; Burk O; Fromm MF; Thon KP; Eichelbaum M; Kivistö KT
Clin Pharmacol Ther; 2004 Mar; 75(3):172-83. PubMed ID: 15001968
[TBL] [Abstract][Full Text] [Related]
8. Gomisin A is a Novel Isoform-Specific Probe for the Selective Sensing of Human Cytochrome P450 3A4 in Liver Microsomes and Living Cells.
Wu JJ; Ge GB; He YQ; Wang P; Dai ZR; Ning J; Hu LH; Yang L
AAPS J; 2016 Jan; 18(1):134-45. PubMed ID: 26361765
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of expression of cytochrome P450 3A4 in a human liver epithelial cell line in differentiation-inducing conditions.
Yamazaki T; Tokiwa T
Hum Cell; 2021 May; 34(3):750-758. PubMed ID: 33495943
[TBL] [Abstract][Full Text] [Related]
10. Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI).
Miyata S; Saku N; Akiyama S; Javaregowda PK; Ite K; Takashima N; Toyoda M; Yura K; Kimura T; Nishina H; Nakazawa A; Kasahara M; Nonaka H; Kiyono T; Umezawa A
Stem Cell Res Ther; 2022 Jan; 13(1):6. PubMed ID: 35012658
[TBL] [Abstract][Full Text] [Related]
11. Arsenite and its metabolites, MMA(III) and DMA(III), modify CYP3A4, PXR and RXR alpha expression in the small intestine of CYP3A4 transgenic mice.
Medina-Díaz IM; Estrada-Muñiz E; Reyes-Hernández OD; Ramírez P; Vega L; Elizondo G
Toxicol Appl Pharmacol; 2009 Sep; 239(2):162-8. PubMed ID: 19084030
[TBL] [Abstract][Full Text] [Related]
12. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
Han SY; Zhao HY; Zhou N; Zhou F; Li PP
J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
[TBL] [Abstract][Full Text] [Related]
13. PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo.
Klein K; Thomas M; Winter S; Nussler AK; Niemi M; Schwab M; Zanger UM
Clin Pharmacol Ther; 2012 Jun; 91(6):1044-52. PubMed ID: 22510778
[TBL] [Abstract][Full Text] [Related]
14. Gender Difference of Hepatic and Intestinal CYP3A4 in CYP3AHumanized Mice Generated by a Human Chromosome-engineering Technique.
Kobayashi K; Abe C; Endo M; Kazuki Y; Oshimura M; Chiba K
Drug Metab Lett; 2017 Nov; 11(1):60-67. PubMed ID: 28393714
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.
Koe XF; Lim EL; Seah TC; Amanah A; Wahab HA; Adenan MI; Sulaiman SF; Tan ML
Food Chem Toxicol; 2013 Oct; 60():98-108. PubMed ID: 23876819
[TBL] [Abstract][Full Text] [Related]
16. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes.
Liddle C; Goodwin BJ; George J; Tapner M; Farrell GC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2411-6. PubMed ID: 9661620
[TBL] [Abstract][Full Text] [Related]
17. The role of CYP3A4 mRNA transcript with shortened 3'-untranslated region in hepatocyte differentiation, liver development, and response to drug induction.
Li D; Gaedigk R; Hart SN; Leeder JS; Zhong XB
Mol Pharmacol; 2012 Jan; 81(1):86-96. PubMed ID: 21998292
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of human cytochrome b5 increases expression of cytochrome P450 3A4 in Escherichia coli by stabilizing mRNA.
Dong MS; Lee SB; Kim HJ
Protein Expr Purif; 2013 May; 89(1):44-50. PubMed ID: 23459292
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of fatty acids contributed to induction of hepatic CYP3A4 activity induced by diabetes - in vitro evidence from HepG2 cell and Fa2N-4 cell lines.
Hu N; Hu M; Duan R; Liu C; Guo H; Zhang M; Yu Y; Wang X; Liu L; Liu X
J Pharmacol Sci; 2014; 124(4):433-44. PubMed ID: 24739263
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CYP3A5 attenuates inducibility and activity of CYP3A4 in HepG2 cells.
Kuang Z; Huang Z; Li Y; Yang G; Liu M; Yuan H
Mol Med Rep; 2015 Apr; 11(4):2868-74. PubMed ID: 25434721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
